GlassScriptPhysician profile
Tami B Pearlstein
NPI 1487853867
$1,868.57
in general payments reported to CMS, 2019-2025
19 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $144 · 2023: $1,143 · 2024: $134 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $744 · Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $743.99 |
| Food and Beverage | $696.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $1,019.07 | 2022-2023 | V.A.C. Veraflo, Prevena, Bair Hugger |
| Janssen Biotech, INC. | $167.71 | 2022-2025 | Erleada, Tremfya |
| Antares Pharma, INC. | $124.74 | 2021 | |
| Ethicon US, LLC | $107.28 | 2021-2025 | Stratafix, Dermabond, Vistaseal |
| Sumitomo Pharma America, INC. | $57.64 | 2024-2025 | Orgovyx |
| Heron Therapeutics, INC. | $46.46 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $44.48 | 2022-2024 | Xiaflex, Aveed |
| Solventum Corporation | $43.82 | 2024 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Intuitive Surgical, INC. | $40.86 | 2021 | |
| Olympus America INC. | $32.69 | 2023 | Olympus, Visera Elite II Video System Center, Endoeye Flex 3d Deflectable Videoscope |
| Ferring Pharmaceuticals INC. | $29.77 | 2025 | Adstiladrin |
| Abbvie INC. | $26.73 | 2021-2022 | |
| Fresenius Kabi USA, LLC | $25.74 | 2023 | |
| Convatec INC. | $20.16 | 2024 | |
| Integra Lifesciences Corporation | $17.66 | 2024 | Tcc-Ez |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $16.83 | 2025 | Apligraf |
| Abbott Laboratories | $16.45 | 2023 | Cardiomems |
| Amgen INC. | $16.34 | 2023 | Tavneos |
| Octapharma USA, INC. | $14.14 | 2023 | Octagam Immune Globulin (Human) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tami Pearlstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.